Ferrochelatase (protoheme ferrolyase, E.C. 4.99.1.1), the terminal enzyme in the heme biosynthetic pathway, catalyzes the insertion of ferrous iron into protoporphyrin IX to form protoheme. In eukaryotes, the protein is associated with the inner surface of the inner mitochondrial membrane, and in higher animals the enzyme contains a [2Fe±2S] cluster. This cluster is highly sensitive to NO and is coordinated by four Cys residues whose spacing in the primary sequence is unique. Ferrochelatase from Drosophila melanogaster has been expressed in Escherichia coli with an amino-terminal sixhistidine tag and puri®ed to homogeneity. The protein has been crystallized with the [2Fe±2S] cluster intact. The crystals belong to space group I422, with unit-cell dimensions a = b = 158.1, c = 171.2 A Ê and two molecules in the asymmetric unit, and diffract to 3.0 A Ê resolution.
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Introduction
The enzyme ferrochelatase (E.C. 4.99.1.1) catalyzes the insertion of ferrous iron into protoporphyrin IX to form protoheme IX (heme). This enzyme is found in essentially all prokaryotes and eukaryotes, with the exception of those few organisms which either do not contain heme or obtain heme from a host organism. To date, over two dozen DNA sequences for ferrochelatase have been obtained although no Archael ferrochelatases have been reported. When characterized, the enzyme has been shown to utilize ferrous iron, zinc and divalent cobalt, except in Bacillus subtilis where divalent copper, but not cobalt, is used (Hansson & Hederstedt, 1994) and in Azospirillum brasilense where divalent nickel is also utilized (see Dailey, 1996) . The divalent heavy-metal ions of lead, cadmium, manganese and mercury are competitive inhibitors of ferrochelatase (Dailey, 1988) . Trivalent and monovalent metal ions have no effect on enzyme activity and are not substrates. For the porphyrin substrate IX isomers of porphyrin with vinyl, hydroxyethyl, ethyl or hydrogen as substituents at the 2,4 positions are acceptable.
With the exception of ferrochelatase from B. subtilis, which is a soluble protein (Hansson & Hederstedt, 1994) , all are membrane-associated. In prokaryotes, ferrochelatase is usually associated with the cytoplasmic membrane (Dailey, 1990) . In eukaryotes, it is nuclearencoded and cytoplasmically synthesized, and the precursor form of the enzyme is translocated to the matrix side of the inner mitochondrial membrane in an energy-requiring step which also involves proteolytic processing of the protein to its mature size (Karr & Dailey, 1988) . The eukaryotic enzymes possess an additional 30±50 amino-acid residues at the carboxyl terminus which are lacking in bacteria. The function of this extension is unknown, but its removal in yeast or animal ferrochelatase results in loss of enzyme activity (Dailey, Sellers et al., 1994) . In animal ferrochelatases, there exists a [2Fe±2S] cluster (Dailey, Finnegan et al., 1994) which is coordinated by three Cys residues which are present in the carboxyl terminal 30-residue extension (Crouse et al., 1996) and a fourth Cys residue located approximately 200 residues to the amino-terminal side of the second coordinating Cys residue (Sellers et al., 1998) . This cluster, which has a unique Cys±(x 207 )±Cys± (x 2 )±Cys±(x 4 )±Cys spacing, is very sensitive to NO in vivo and in vitro . This NO-sensitive cluster not only gives animal ferrochelatases a unique property, but also makes the protein considerably more thermolabile than the corresponding prokaryotic enzymes. The purpose and function of this NO-sensitive [2Fe±2S] cluster is unknown, but it has been suggested that it is involved in an immune response to infection via regulation of heme/iron homeostasis, since increased NO production by macrophages during an infection results in reduction of cellular heme synthesis and an increase in heme catabolism. Determination of the crystal structure for animal ferrochelatase may help to answer this question as well as to provide a basis for understanding the catalytic functioning of this protein.
crystallization papers
The catalytic model for ferrochelatase was put forward over ten years ago and has slowly gathered experimental support (see Lavallee, 1988; Dailey, 1997) . In this model, the enzyme is proposed to ®rst bind ferrous iron and then porphyrin. Metallation is facilitated by enzyme-catalyzed porphyrin macrocycle distortion. Metal insertion results in the formation of protoheme, which is released as a planar moiety. Data in support of this model involve thermodynamic consideration of metal insertion into a distorted macrocyclic porphyrin (Lavallee, 1988) , tight-binding competitive inhibition of the enzyme by N-alkylporphyrins (as transition-state analogs; Dailey & Fleming, 1983) , catalytic antibodies which mimic the ferrochelatase reaction (Cochran & Schultz, 1990 ) and, most recently, resonance Raman studies on porphyrin bound to ferrochelatase (Blackwood et al., 1997) .
Recently, the crystal structure of ferrochelatase from the bacterium B. subtilis was published (Al-Karadaghi et al., 1997) . This structure, while representing a landmark for ferrochelatase research, revealed little about the potential catalytically important residues in the putative active-site region, since no substrate-bound or product-bound forms of the protein were crystallized. In addition this protein, unlike other ferrochelatases, does not appear to be membrane-associated and its metal-utilization pro®le is unique among known ferrochelatases. As a bacterial ferrochelatase, it also lacks the carboxylterminal extension and [2Fe±2S] cluster. Finally, a signi®cant helix±loop±helix region which appears to be part of, or adjacent to, the putative active site, is in a region where the B. subtilis protein contains 14 fewer amino acids than are found in animal ferrochelatases. Overall, the B. subtilis and human ferrochelatases are only 12% identical. Thus, in order to understand the animal ferrochelatases, it is necessary to obtain the crystal structure of one of these proteins.
During the course of our studies, we have expressed and characterized eukaryotic ferrochelatases from human (Dailey, Sellers et al., 1994) , mouse (Sellers & Dailey, 1997) , chicken, frog (Day et al., 1998) , Saccharomyces cerevisiae (Eldridge & Dailey, 1992) and Drosophila melanogaster (Sellers et al., 1998) . While these are all highly similar, except for the lack of a [2Fe±2S] cluster in the S. cerevisiae enzyme, they possess distinct solubilities. It was found that the expressed Drosophila ferrochelatase with a His 6 tag yielded high-purity protein preparations which were more stable to storage and crystallization conditions than were the other proteins. Preliminary crystallographic studies on the Drosophila ferrochelatase are reported herein.
Crystallization
Drosophila ferrochelatase cDNA was isolated using complementation of Escherichia coli Áhem H, a ferrochelatase-de®cient strain (Miyamoto et al., 1991) , with a ! ZAP cDNA library (Stratagene Inc.). The cDNA encoding Drosophila ferrochelatase was ampli®ed by PCR, with two primers which contain NcoI and BgII restriction sites at the 5 H and 3 H ends, respectively. For high levels of expression and simple puri®cation, an expression vector containing a six-histidine terminal leader was constructed (Dailey & Dailey, 1996 SDS±polyacrylamide gel electrophoresis demonstrates a single protein band with a calculated molecular weight of approximately 42 kDa, which corresponds well with the molecular weight of 43 032 Da predicted from the derived amino-acid sequence. The isolated Drosophila ferrochelatase has visible spectral features at 320 nm and broad features around 550 nm, which are characteristic of the [2Fe±2S] cluster present in this protein (Fig. 1) , and has a calculated molar extinction coef®cient of 55 600 M À1 cm À1 at 278 nm. Also seen is an absorbance peak at 423 nm resulting from some residual protein-bound heme (enzyme product). It is not known if the crystal examined contained bound heme.
Hampton Crystal Screens I, II and MEMBFAC (Hampton Research, Laguna Hills CA) were used to screen for suitable crystallization conditions. Screening was performed at 277, 281 and 291 K using the hanging-drop vapor-diffusion technique. Drops (4 ml) contained equal volumes of protein concentrate and reservoir solution. The only detectable crystals observed in the initial screen were from a leaking well equilibrated at 291 K whose initial condi- crystallization papers tions were 18% PEG 400 and 0.1 M ammonium sulfate in 0.1 M sodium HEPES buffer pH 7.5. After accounting for evaporation, these conditions were re®ned and larger crystals (0.1 Â 0.1 Â 0.15 mm) were obtained using a reservoir solution containing 32% PEG 400, 0.3 M ammonium sulfate, 0.04 M NaH 2 PO 4 in 0.1 M sodium HEPES pH 7.5. These crystals were harvested, washed three times with 20% PEG 400, 0.3 M ammonium sulfate in 0.1 M sodium HEPES buffer pH 7.5 to remove any surface ®lm covering the crystals, ground by sonication and used as seed crystals in new preparations. Crystals measuring 0.1 Â 0.1 Â 0.2 mm (Fig. 2) could be obtained at 281 K using seeded drops and a reservoir solution containing 29% PEG 400, 0.3 M ammonium sulfate, 0.04 M NaH 2 PO 4 in 0.1 M sodium HEPES pH 7.5. Although the microseeding technique produced larger crystals, the crystals were always embedded in a gelatinous matrix which may be a limiting factor in crystal growth. Addition of detergents from the Hampton Research detergent screen kit had little effect on crystal size, which was unexpected as ferrochelatase is a membrane-associated protein which requires detergents for solubilization.
Space-group determination and data collection
For data collection, a crystal measuring 0.1 Â 0.1 Â 0.2 mm was mounted in a 0.2 mm rayon loop and¯ash-cooled to 100 K in a nitrogen-gas cold stream (Oxford Cryosystems Cryostream). A data set to 3.2 A Ê resolution was collected on a Bruker 2X2 Mosaic CCD detector at ID17 (IMCA-CAT), the Advanced Photon Source, Argonne National Laboratory, using the unfocused undulator beam. The data set consisted of 400 0.25 data frames, each exposed for 3 s.
The data were indexed, integrated and scaled using HKL2000 (Otwinowski & Minor, 1997) and yielded 16 688 unique re¯ections (99% complete) with an average I/'(I) of 6.11, re¯ecting the diffraction quality and size of the crystal used in the experiment. After scaling, R merge for the data set was 0.14, which re¯ects the weak diffraction quality of the small crystal. The data indexed in a body-centered tetragonal lattice with a = b = 158.1 and c = 171.2 A Ê . Analysis of the three-dimensional diffraction pattern indicated that the space group was I422. Assuming two molecules per asymmetric unit, the Matthews coef®cient (Matthews, 1968 ) is calculated to be 3.10 A Ê 3 Da À1 , which corresponds to a solvent content of 58%, which is in the range typical for most protein crystals.
